Cytoreduction in Advanced Ovarian Cancer: ' Keep the Status Quo ' Cytoreduction in Advanced Ovarian Cancer: ' Keep the Status Quo '
A retrospective case-control study showed that optimal cytoreductive surgery is an independent predictor of overall survival, even when controlling for response to chemotherapy.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Hematology | Ovarian Cancer | Ovaries | Study